Big savings are coming in 2026. See the list of the first 10 drugs with prices negotiated by Medicare, including Eliquis, ...

In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Bristol Myers Squibb and Pfizer will begin offering ...

Eliquis and Xarelto, two blood-thinning medications that are already among Medicare's costliest, have seen their list prices more than double since entering the market, finds a new report by Patients ...

CMS released its highly anticipated list of 10 drugs subject to Medicare price negotiations Tuesday, which includes popular blood clot prevention drugs Eliquis and Xarelto and diabetes drugs Jardiance ...

When Johnson & Johnson’s Xarelto entered the market in 2011 and Bristol Myers Squibb’s Eliquis did the same in 2013, list prices for the popular blood thinners were $218 and $250, respectively, for a ...

Medicare, the health insurance program for people over 65 years old, said it will start negotiating prices on 10 drugs, part of its mandate under the Inflation Reduction Act to lower prescription ...

The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs. President Joe Biden's ...

The medications treat heart disease, certain cancers, diabetes and autoimmune diseases. Medicare enrollees currently spend thousands of dollars on these drugs, according to the Department of Health ...

FILE - President Joe Biden speaks about health care and prescription drug costs at the University of Nevada, Las Vegas, Wednesday, March 15, 2023, in Las Vegas. Biden’s administration will announce on ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best affordable healthcare stocks to buy now. On December 22, ...